US 8754081
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
granted A61PA61P35/00
Quick answer
US patent 8754081 (Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00